Press release
Elevating Concerns Skin Cancer Prevalence Fuels Demand For Innovative Drugs: Strengthening the Growth Trajectory of the Skin Cancer Drugs Market
Skin Cancer Drugs
What Is the Expected CAGR for the Skin Cancer Drugs Market Through 2025?
The market size for skin cancer medications has witnessed a rapid expansion over recent years. An increase from $4.72 billion in 2024 to $5.3 billion in 2025 is projected, reflecting a compound annual growth rate (CAGR) of 12.2%. Factors contributing to growth during the historical period include a rise in skin cancer cases, concerns about sun exposure and UV radiation, advancements in diagnostic techniques, demographic shifts and an aging population, as well as regulatory endorsements and clinical studies.
What's the Projected Size of the Global Skin Cancer Drugs Market by 2029?
In the coming years, the market for skin cancer drugs is expected to experience a swift expansion. The market is predicted to reach the value of ""$8.17 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.4%. The anticipated growth for the forecast period can be ascribed to advancements in immunotherapy, precision medicine, along with biomarker research as well as patient education and awareness initiatives. Global research collaborations and the growth of therapeutic options also contribute to market expansion. The forecast period will also witness significant trends including enhanced efficacy through combination therapies, increased preference towards personalized medicine approaches, the advent of topical treatments, heightened emphasis on early detection and prevention, and the exploration of innovative drug delivery systems.
View the full report here:
https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report
Top Growth Drivers in the Skin Cancer Drugs Industry: What's Accelerating the Market?
The escalating occurrence of skin cancer is fueling the need for Skin Cancer medications. To handle the increasing skin cancer instances, there is a growing creation of innovative skin cancer treatments. Based on data from The American Cancer Society (an organization based in the US), there will be about 99,780 freshly diagnosed melanoma skin cancer cases and roughly 7,650 melanoma skin cancer mortalities each year in 2022. This trend is subsequently enhancing the demand for skin cancer treatments and propelling the growth of the skin cancer drug industry.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2564&type=smp
What Trends Will Shape the Skin Cancer Drugs Market Through 2029 and Beyond?
Firms in the Skin Cancer Market are progressively seeking Strategic Alliances with other players in the industry. These alliances are considered beneficial for enhancing research and development abilities, speeding up the creation of new drugs, and strengthening the company's competitive stance in the market. For instance, Leo Pharma has joined forces with PellePharm to produce a drug for a rare type of skin cancer known as Gorlin syndrome. MorphoSys and LEO Pharma have collaborated strategically to develop antibodies for skin cancer treatment. Furthermore, Pfizer has established a strategic alliance with Merck KGaA for the production of an innovative skin cancer drug.
What Are the Main Segments in the Skin Cancer Drugs Market?
The skin cancer drugs market covered in this report is segmented -
1) By Type: Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma
2) By Drug Class: Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs
3) By End Users: Hospitals, Cancer Research Centers, Clinics
Subsegments:
1) By Actinic Keratoses (AK): Cryotherapy Treatments, Topical Medications, Photodynamic Therapy (PDT), Laser Therapy
2) By Basal Cell Carcinoma (BCC): Surgical Excision, Mohs Micrographic Surgery, Radiation Therapy, Topical Therapies
3) By Squamous Cell Carcinoma (SCC): Surgical Excision, Cryosurgery, Electrosurgery and Curettage, Radiation Therapy
4) By Melanoma: Surgical Excision, Immunotherapy, Targeted Therapy, Chemotherapy and Radiation
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2564&type=smp
Which Top Companies are Driving Growth in the Skin Cancer Drugs Market?
Major companies operating in the skin cancer drugs market include Pfizer Inc., Meda Pharmaceuticals, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Mylan N.V., Daiichi Sankyo Company Limited, Bausch Health Companies Inc., Valeant Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Ipsen Pharma, Varian Medical Systems Inc., Kyowa Kirin Co. Ltd., QIAGEN N.V., Elekta AB, Cannabis Science Inc., LEO Pharma A/S, Aqua Pharmaceuticals, iCAD Inc., AB Science, Cellceutix Corporation, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Seattle Genetics Inc.
Which Regions Will Dominate the Skin Cancer Drugs Market Through 2029?
North America was the largest region in the skin cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the global skin cancer drugs market during the forecast period. The regions covered in the skin cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2564
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
#Reach Out to Us#
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevating Concerns Skin Cancer Prevalence Fuels Demand For Innovative Drugs: Strengthening the Growth Trajectory of the Skin Cancer Drugs Market here
News-ID: 4183126 • Views: …
More Releases from The Business Research Company
Bronchodilators Market Expected to Achieve 6.3% CAGR by 2029: Growth Forecast In …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Bronchodilators Market Size By 2025?
The market size for bronchodilators has seen significant growth in the past few years. The market is expected to increase from $32.93 billion in 2024 to $35.31 billion in 2025, registering a compound annual growth rate (CAGR) of 7.2%. The…
Navigating the Future: Artificial Intelligence (AI) In Biopharmaceuticals Market …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Artificial Intelligence (AI) In Biopharmaceuticals Market Size Growth Forecast: What to Expect by 2025?
The market size of artificial intelligence (AI) in the biopharmaceuticals sector has seen an incredible rise in recent years. The predictions indicate an increase from $1.59 billion in 2024 to $2.1 billion in 2025, featuring…
Bionl.AI Platform Revolutionizes Biomedical Research Industry Trends Gaining Mom …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
AI In Bioinformatics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for AI in bioinformatics has seen a dramatic expansion in the past few years. The market, which was valued at $4.3 billion in 2024, is projected to reach $6.14 billion in 2025,…
Pharmacovigilance: A Leading Driver Behind Research And Development Drive Growth …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Pharmacovigilance Industry Market Size Be by 2025?
Recently, the pharmacovigilance market has expanded significantly. The market size is projected to escalate from $8.58 billion in 2024 to $9.64 billion in 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 12.4%. The historical growth can be linked…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
